Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes
- PMID: 33843016
- DOI: 10.1007/s00345-021-03687-5
Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes
Abstract
Purpose: To provide a systematic analysis of the comparative outcomes of robot-assisted radical prostatectomy (RARP) versus laparoscopic radical prostatectomy (LRP) in the treatment of prostate cancer based on the best currently available evidence.
Methods: An independent systematic review of the literature was performed up to February 2021, using MEDLINE®, EMBASE®, and Web of Science® databases. Preferred reporting items for systematic review and meta-analysis (PRISMA) recommendations were followed to design search strategies, selection criteria, and evidence reports. The quality of the included studies was determined using the Newcastle-Ottawa scale for non-randomized controlled trials. Demographics and clinical characteristics, surgical, pathological, and functional outcomes were collected.
Results: Twenty-six studies were identified. Only 16 "high-quality" (RCTs and Newcastle-Ottawa scale 8-9) studies were included in the meta-analysis. Among the 13,752 patients included, 6135 (44.6%) and 7617 (55.4%) were RARP and LRP, respectively. There was no difference between groups in terms of demographics and clinical characteristics. Overall and major complication (Clavien-Dindo ≥ III) rates were similar in LRP than RARP group. The biochemical recurrence (BCR) rate at 12months was significantly lower for RARP (OR: 0.52; 95% CI 0.43-0.63; p < 0.00001). RARP reported lower urinary incontinence rate at 12months (OR: 0.38; 95% CI 0.18-0.8; p = 0.01). The erectile function recovery rate at 12months was higher for RARP (OR: 2.16; 95% CI 1.23-3.78; p = 0.007).
Conclusion: Current evidence shows that RARP offers favorable outcomes compared with LRP, including higher potency and continence rates, and less likelihood of BCR. An assessment of longer-term outcomes is lacking, and higher cost remains a concern of robotic versus laparoscopic prostate cancer surgery.
Keywords: Laparoscopic radical prostatectomy; Meta-analysis; Prostatic cancer; Robotic radical prostatectomy.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Comment in
-
The devil is still in the details of robotic assisted radical prostatectomy data.World J Urol. 2022 May;40(5):1239-1240. doi: 10.1007/s00345-022-03962-z. Epub 2022 Feb 14. World J Urol. 2022. PMID: 35157104 No abstract available.
References
-
- Porpiglia F, Fiori C, Bertolo R, Manfredi M, Mele F, Checcucci E, De Luca S, Passera R, Scarpa RM (2018) Five-year outcomes for a prospective randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy. Eur Urol Focus 4:80–86 - PubMed
-
- Autorino R, Porpiglia F (2020) Robotic surgery in urology: the way forward. World J Urol 38:809–811 - PubMed
-
- Martini A, Falagario UG, Villers A et al (2020) Contemporary techniques of prostate dissection for robot-assisted prostatectomy. Eur Urol. https://doi.org/10.1016/j.eururo.2020.07.017 - DOI - PubMed
-
- Traboulsi SL, Nguyen DD, Zakaria AS, Law KW, Shahine H, Meskawi M, Negrean C, Karakiewicz PI, El HA, Zorn KC (2020) Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer. World J Urol. https://doi.org/10.1007/s00345-020-03096-0 - DOI - PubMed
-
- Minafra P, Carbonara U, Vitarelli A, Lucarelli G, Battaglia M, Ditonno P (2021) Robotic radical perineal prostatectomy: tradition and evolution in the robotic era. Curr Opin Urol 31:11–17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
